✦ LIBER ✦

Antithrombotic Therapy for Patients with Valvular Heart Disease

✍ Scribed by Alec Vahanian

Publisher: Urban and Vogel
Year: 2008
Tongue: German
Weight: 315 KB
Volume: 33
Category: Article
ISSN: 0340-9937
DOI: 10.1007/s00059-008-3079-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding after antithrombotic therapy in

Bleeding after antithrombotic therapy in patients with acute ischemic heart disease

✍ Marc Cohen; Karen P. Alexander; Sunil V. Rao 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 422 KB

Long-term cabergoline therapy is not ass

Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas

✍ Sophie Vallette; Karim Serri; Juan Rivera; Patricia Santagata; Sophie Delorme; N 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 165 KB

Dopamine agonists and valvular heart dis

Dopamine agonists and valvular heart disease in Japanese patients with Parkinson's disease

✍ Masahiro Nagai; Noriko Nishikawa; Hayato Yabe; Hiroyoko Moritoyo; Takashi Morito 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 242 KB

Antithrombotic therapies in patients wit

Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician

✍ Tiago L. L. Leiria; Renato D. Lopes; Judson B. Williams; Jason N. Katz; Renato A 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 227 KB

High risk factors for valvular heart dis

High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson’s disease

✍ Tomoko Oeda; Motoko Masaki; Kenji Yamamoto; Eiji Mizuta; Naoyuki Kitagawa; Tsuyo 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 245 KB

Complications of cardiac catheterization

Complications of cardiac catheterization and angiography in patients with valvular heart disease

✍ Folland, Edward D. ;Oprian, Charles ;Giacomini, John ;Schechter, Eliot ;Shabetai 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

and the participants in the VA Cooperative Study on Valvular Heart Disease' Complications were surveyed prospectively in 2,029 catheterizations performed on 1,483 patients from the 13 centers participating in the VA Cooperative Study on Valvular Heart Disease. Complications were reported in 6.9% of